These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 9546344

  • 1. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R.
    Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
    [Abstract] [Full Text] [Related]

  • 2. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 3. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
    Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O, Seregard S.
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
    [Abstract] [Full Text] [Related]

  • 4. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
    Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R.
    Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
    [Abstract] [Full Text] [Related]

  • 5. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S.
    Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
    [Abstract] [Full Text] [Related]

  • 6. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
    Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O, Seregard S.
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
    [Abstract] [Full Text] [Related]

  • 7. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P, Kiratli H, Saglam A, Söylemezoglu F, Hascelik G.
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [Abstract] [Full Text] [Related]

  • 8. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 9. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 10. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 12. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC, Grierson I, Hiscott P, Hunt JA.
    Invest Ophthalmol Vis Sci; 2000 Sep 01; 41(10):3085-94. PubMed ID: 10967068
    [Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 14. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.
    Invest Ophthalmol Vis Sci; 2009 Apr 01; 50(4):1559-65. PubMed ID: 19029026
    [Abstract] [Full Text] [Related]

  • 16. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G.
    Cancer Res; 1998 Nov 15; 58(22):5157-67. PubMed ID: 9823327
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, Kramer RH.
    Int J Oncol; 2004 Oct 15; 25(4):831-40. PubMed ID: 15375530
    [Abstract] [Full Text] [Related]

  • 18. met and HGF-SF in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, White W.
    EXS; 1993 Oct 15; 65():329-39. PubMed ID: 8380740
    [Abstract] [Full Text] [Related]

  • 19. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J.
    Hepatology; 1997 Dec 15; 26(6):1458-66. PubMed ID: 9397985
    [Abstract] [Full Text] [Related]

  • 20. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M, Rong S, Anver M, Vande Woude GF.
    Oncogene; 1996 Aug 15; 13(4):853-6. PubMed ID: 8761307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.